Early research (Phase 1)Study completedNCT04330664
What this trial is testing
Adagrasib in Combination With TNO155 in Patients With Cancer (KRYSTAL 2)
Who this might be right for
Advanced CancerMetastatic CancerMalignant Neoplastic Disease
Mirati Therapeutics Inc. 86